The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis

Clinical Utility of Serum Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 Concentrations in the Assessment of Liver Fibrosis due to Chronic Hepatitis B

(2013) B Liang et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis

(2011) A. B. Jazwinski et al.   JOURNAL OF VIRAL HEPATITIS

Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels

(2011) Jae Y. Cheong et al.   LIVER INTERNATIONAL

Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis

(2010) Pamela Valva et al.   JOURNAL OF MEDICAL VIROLOGY

Keratin 18 phosphorylation as a progression marker of chronic hepatitis B

(2010) Ying Shi et al.   Virology Journal

Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease

(2009) Y. YILMAZ   ALIMENTARY PHARMACOLOGY & THERAPEUTICS